(Q84038259)
Statements
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis (English)
P W O'Connor
A Goodman
L Kappos
F D Lublin
D H Miller
C Polman
R A Rudick
W Aschenbach
scientific article published on 04 May 2011